13F HOLDINGS REPORT
Catalio Capital Management, LP
Quarter ended Q4 2025 · Filed February 17, 2026 · Accession 0001958125-26-000002
Total Value
$565.8M
Positions
45
Other Managers
0
Confidential Omitted
No
Holdings (45)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | GILD | 289,312 | $35.5M | 6.28% |
| 2 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 647,899 | $34.9M | 6.18% |
| 3 | BOSTON SCIENTIFIC CORP | BSX | 360,428 | $34.4M | 6.07% |
| 4 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 410,700 | $31.4M | 5.55% |
| 5 | ELI LILLY & CO | LLY | 25,923 | $27.9M | 4.92% |
| 6 | DIANTHUS THERAPEUTICS INC | DNTH | 653,572 | $26.9M | 4.76% |
| 7 | ASCENDIS PHARMA A/S | ASND | 119,265 | $25.4M | 4.49% |
| 8 | SYNDAX PHARMACEUTICALS INC | SNDX | 1,196,807 | $25.1M | 4.44% |
| 9 | JOHNSON & JOHNSON | JNJ | 120,840 | $25.0M | 4.42% |
| 10 | REGENERON PHARMACEUTICALS | REGN | 29,797 | $23.0M | 4.07% |
| 11 | STRUCTURE THERAPEUTICS INC | GPCR | 252,901 | $17.6M | 3.11% |
| 12 | SOLENO THERAPEUTICS INC | SLNO | 360,340 | $16.7M | 2.95% |
| 13 | CYTOKINETICS INC | CYTK | 258,381 | $16.4M | 2.90% |
| 14 | EDWARDS LIFESCIENCES CORP | EW | 187,048 | $15.9M | 2.82% |
| 15 | INTUITIVE SURGICAL INC | ISRG | 27,209 | $15.4M | 2.72% |
| 16 | NATERA INC | NTRA | 62,273 | $14.3M | 2.52% |
| 17 | ADAPTIVE BIOTECHNOLOGIES COR | ADTI | 821,195 | $13.3M | 2.36% |
| 18 | ABIVAX SA | AAVXF | 98,514 | $13.3M | 2.35% |
| 19 | SUPERNUS PHARMACEUTICALS INC | SUPN | 257,465 | $12.8M | 2.26% |
| 20 | FRACTYL HEALTH INC | GUTS | 5,491,866 | $12.1M | 2.14% |
| 21 | MINERALYS THERAPEUTICS INC | MLYS | 331,849 | $12.0M | 2.13% |
| 22 | PHATHOM PHARMACEUTICALS INC | PHAT | 698,996 | $11.6M | 2.05% |
| 23 | ADMA BIOLOGICS INC | ADMA | 564,461 | $10.3M | 1.82% |
| 24 | ARCELLX INC | ACLX | 156,109 | $10.2M | 1.80% |
| 25 | DYNE THERAPEUTICS INC | DYN | 519,715 | $10.2M | 1.80% |
| 26 | DISC MEDICINE INC | IRON | 110,427 | $8.8M | 1.55% |
| 27 | OCULAR THERAPEUTIX INC | OCUL | 714,501 | $8.7M | 1.53% |
| 28 | SEPTERNA INC | SEPN | 294,360 | $8.2M | 1.45% |
| 29 | PROTARA THERAPEUTICS INC | TARA | 1,446,254 | $7.7M | 1.36% |
| 30 | UNIQURE NV | QURE | 288,345 | $6.9M | 1.22% |
| 31 | OLEMA PHARMACEUTICALS INC | OLMA | 267,058 | $6.7M | 1.18% |
| 32 | TERNS PHARMACEUTICALS INC | TERN | 136,958 | $5.5M | 0.98% |
| 33 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 162,550 | $3.7M | 0.66% |
| 34 | HEARTFLOW INC | HTFL | 113,857 | $3.3M | 0.59% |
| 35 | GRAIL INC | GRAL | 30,313 | $2.6M | 0.46% |
| 36 | FULCRUM THERAPEUTICS INC | FULC | 201,301 | $2.3M | 0.40% |
| 37 | BILLIONTOONE INC | BLLN | 25,505 | $2.1M | 0.37% |
| 38 | ELEDON PHARMACEUTICALS INC | ELDN | 1,259,820 | $1.9M | 0.34% |
| 39 | HYPERFINE INC | HYPR | 1,320,041 | $1.3M | 0.23% |
| 40 | PALVELLA THERAPEUTICS INC NE | PVLA | 10,452 | $1.1M | 0.19% |
| 41 | KARYOPHARM THERAPEUTICS INC | KPTI | 142,984 | $1.1M | 0.19% |
| 42 | METAGENOMI INC | MGX | 528,993 | $856,969 | 0.15% |
| 43 | ATAI BECKLEY NV | N0731H103 | 196,858 | $805,149 | 0.14% |
| 44 | OUTSET MED INC | OM | 118,279 | $438,815 | 0.08% |
| 45 | SENSEI BIOTHERAPEUTICS INC | SNSE | 14,718 | $157,041 | 0.03% |